48.9%
% surviving 5 years after diagnosis (relative survival, SEER 9)
No current source auditAll sources · source collection
SEER Cancer Statistics Review 1975-2017, Table 2.9: All Cancer Sites — Relative Survival by Year of Diagnosis
National Cancer Institute (NIH), Surveillance Research Program · 2020
Population measured
Patients diagnosed with cancer in SEER 9 registry areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta), all races, both sexes
Source notes & limitations
5-year relative survival rates by year of diagnosis, 1975-2016. SEER 9 registries cover ~10% of US population. Ederer II method.
Where this source appears
5 records across 5 decades and countries. Documented gaps are included; a source cited for a gap does not establish a value.
0 of 5 records have a current source audit. A transcription check reads a declared numeric field from a pinned local source file; a calculation replay reads its operands and applies the declared method and rounding rule. A source audit does not independently validate the source or every claim in a record. The date is the last successful local audit; the build checks that its bindings still match.
US · 1970s
US · 1980s
50.2%
% surviving 5 years after diagnosis (relative survival, SEER 9)
No current source auditUS · 1990s
60.4%
% surviving 5 years after diagnosis (relative survival, SEER 9)
No current source auditUS · 2000s
66.0%
% surviving 5 years after diagnosis (relative survival, SEER 9)
No current source auditUS · 2010s
69.7%
% surviving 5 years after diagnosis (relative survival, SEER 9)
No current source audit